Key result
Phenomapping stratifies 3-year mortality, stroke, and MACE risk in post-MI new-onset AF.
Why the study?
Existing risk stratification tools perform poorly in patients with new-onset AF after MI, failing to capture multidimensional risk.
Does phenotype-based risk stratification using PCA improve prediction of adverse outcomes in patients with new-onset AF following MI?
Cohort (n=451)
Does phenotype-based risk stratification using PCA improve prediction of adverse outcomes in patients with new-onset AF following MI?
Data-driven phenomapping using echocardiographic and clinical variables accurately stratifies risk of adverse outcomes in patients with new-onset AF after myocardial infarction.
Phenomapping may support risk stratification in new-onset AF after MI; leaves open added value over standard tools pending prospective validation.
Background Atrial fibrillation (AF) after myocardial infarction (MI) is associated with significant morbidity and mortality, yet existing risk stratification tools perform poorly in this population. Conventional predictors fail to capture multidimensional risk, while data‐driven approaches may identify latent phenotypes with improved prognostic value. Aims We sought to identify phenotypes of new‐onset AF after MI using principal component analysis (PCA), evaluate their association with adverse outcomes, and develop a simple decision‐tree model for clinical risk stratification. Methods We analyzed 451 patients with new‐onset AF after MI. PCA identified low‐, intermediate‐, and high‐risk phenogroups. The primary endpoint was 3‐year mortality, stroke, or MACE. Kaplan–Meier and multivariable Cox models assessed outcomes. Decision trees predicted phenogroup membership, with angiographic features compared across risk tiers. Results PCA identified three phenogroups (low, intermediate, high risk) driven mainly by LVESV, LVEDV, LVEF, sex, and CHA 2 DS 2 ‐VASc. Clusters showed clear separation on PCA mapping. Event‐free survival differed significantly across groups (log‐rank p < 0.0001), with the lowest survival in the high‐risk cluster. After multivariable adjustment for clinical risk factors, phenogroups remained independently associated with adverse outcomes. A simplified decision tree using LVEF, CHA 2 DS 2 ‐VASc, LVEDV, age, and TR Vmax predicted risk with 72.3% accuracy, supporting bedside risk stratification in post‐MI AF patient populations. Conclusion Phenomapping identified three distinct AF risk groups with different clinical outcomes. LV size and function were the strongest contributors to phenotypic separation. The decision tree offered a clear, accurate, and interpretable framework that supports a new strategy for identifying appropriate patients with AF after MI.
No takes yet. Share an insight, caveat, or question.
Ammoury et al. (2026) conducted a cohort in New-onset atrial fibrillation following myocardial infarction (n=451). Phenotype-based risk stratification (high-risk phenogroup) vs. Low- and intermediate-risk phenogroups was evaluated on 3-year mortality, stroke, or MACE (p=<0.0001). Phenomapping identified distinct risk groups in patients with new-onset AF after MI, with 3-year event-free survival for mortality, stroke, or MACE differing significantly (log-rank P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: